EBRD BACKS CROATIA PHARMACO WITH EUR20 MILLION LOAN
February 8th, 2015
THE EUROPEAN Bank for Reconstruction & Development (EBRD) is lending Euro EUR20 million to Croatia pharmaco Jadran Galenski Laboratorij d.d. (JGL) to help double its production, hopefully becoming an international player in the sterile solutions segment. The second largest pharmaceutical company in Croatia, it specialises in sterile nose, eye and ear drop solutions, exporting 75% of its production. Croatian Development Bank HBOR will make a parallel loan of EUR32.7 million. This expansion, involving the construction of a new ‘Pharma Valley’ unit, should ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.